Abstract

People with Down syndrome have unique characteristics as a result of the presence of an extra chromosome 21. Regarding cancer, they present a unique pattern of tumors, which has not been fully explained to date. Globally, people with Down syndrome have a similar lifetime risk of developing cancer compared to the general population. However, they have a very increased risk of developing certain tumors (e.g., acute leukemia, germ cell tumors, testicular tumors and retinoblastoma) and, on the contrary, there are some other tumors which appear only exceptionally in this syndrome (e.g., breast cancer, prostate cancer, medulloblastoma, neuroblastoma and Wilms tumor). Various hypotheses have been developed to explain this situation. The genetic imbalance secondary to the presence of an extra chromosome 21 has molecular consequences at several levels, not only in chromosome 21 but also throughout the genome. In this review, we discuss the different proposed mechanisms that protect individuals with trisomy 21 from developing solid tumors: genetic dosage effect, tumor suppressor genes overexpression, disturbed metabolism, impaired neurogenesis and angiogenesis, increased apoptosis, immune system dysregulation, epigenetic aberrations and the effect of different microRNAs, among others. More research into the molecular pathways involved in this unique pattern of malignancies is still needed.

Highlights

  • As Jérôme Lejeune discovered back in 1959 (Lejeune et al, 1959), Down syndrome (DS) is caused by the presence of an extra chromosome 21 (HSA21)

  • Based on scientific evidence and after a thorough bibliographic search, we suggest up to ten reasons that collectively protect people with DS from developing most solid tumors (Figure 1)

  • These findings suggest that the characteristic microenvironment of individuals with DS as a whole, but not their fibroblasts alone, is not conducive to promoting tumor cell proliferation and survival (Ayed et al, 2012)

Read more

Summary

Frontiers in Genetics

People with Down syndrome have unique characteristics as a result of the presence of an extra chromosome 21. Regarding cancer, they present a unique pattern of tumors, which has not been fully explained to date. People with Down syndrome have a similar lifetime risk of developing cancer compared to the general population. They have a very increased risk of developing certain tumors (e.g., acute leukemia, germ cell tumors, testicular tumors and retinoblastoma) and, on the contrary, there are some other tumors which appear only exceptionally in this syndrome (e.g., breast cancer, prostate cancer, medulloblastoma, neuroblastoma and Wilms tumor).

INTRODUCTION
Very increased risk
Reduced risk
Role of Neural Development
Disturbed Metabolism
Increased Cellular Apoptosis and Defective DNA Repair System
Protective Effect of the Tumor Stroma
Impaired Immune System Response
CONCLUSION AND OUTLOOK

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.